Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging - PubMed (original) (raw)

Review

Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging

M S Nobler et al. Brain Res Brain Res Rev. 1999 Nov.

Free article

Abstract

While there is substantial evidence for abnormalities in serotonin (5-HT) neurotransmission in major depressive disorder (MDD), almost all of the findings derive from studies of young adults. Moreover, relatively little research has assessed brain 5-HT transmission in vivo. Neuroendocrine studies do not permit evaluation of a range of brain regions, but only the limited circuitry associated with hormone release. Data from autopsy studies are limited by the difficulties of assessment of the acute clinical picture before death, and by post-mortem artifacts. In vivo neuroimaging techniques overcome many of the methodological limitations of both these approaches. There is a large body of imaging data indicating regional cerebral blood flow (rCBF) and cerebral metabolic rate (rCMR) decrements both with aging and in patients with MDD. While the physiological bases for these phenomena are largely unknown, changes in brain 5-HT function may be involved. Neuroanatomical studies have revealed an intricate network of 5-HT-containing neurons within the cerebral microvasculature, with physiological evidence for serotonergic control of both rCBF and rCMR. Acute pharmacological challenges are available to probe brain 5-HT function. Such paradigms, using neuroendocrine responses as endpoints, have been of some utility in predicting outcome with antidepressant treatment. The role of 5-HT dysregulation in geriatric MDD takes on more importance given concerns regarding putative reduced efficacy of serotonin-specific reuptake inhibitors (SSRIs) in this population. If this is due to diminished responsivity of 5-HT systems, then the ability to identify antidepressant nonresponders via 5-HT challenge in combination with neuroimaging measures may have important clinical utility.

PubMed Disclaimer

Cited by

Cerebrovascular Resistance in Healthy Aging and Mild Cognitive Impairment.
McKetton L, Cohn M, Tang-Wai DF, Sobczyk O, Duffin J, Holmes KR, Poublanc J, Sam K, Crawley AP, Venkatraghavan L, Fisher JA, Mikulis DJ. McKetton L, et al. Front Aging Neurosci. 2019 Apr 12;11:79. doi: 10.3389/fnagi.2019.00079. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31031616 Free PMC article.
Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.
Neigh GN, Nemeth CL, Kelly SD, Hardy EE, Bourke C, Stowe ZN, Owens MJ. Neigh GN, et al. Physiol Behav. 2017 Apr 1;172:24-30. doi: 10.1016/j.physbeh.2016.07.009. Epub 2016 Jul 13. Physiol Behav. 2017. PMID: 27422674 Free PMC article.
Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.
Raz L, Hunter LV, Dowling NM, Wharton W, Gleason CE, Jayachandran M, Anderson L, Asthana S, Miller VM. Raz L, et al. Climacteric. 2016;19(1):49-59. doi: 10.3109/13697137.2015.1116504. Epub 2015 Dec 10. Climacteric. 2016. PMID: 26652904 Free PMC article. Clinical Trial.
Functional neuroimaging in geriatric depression.
Gunning FM, Smith GS. Gunning FM, et al. Psychiatr Clin North Am. 2011 Jun;34(2):403-22, viii. doi: 10.1016/j.psc.2011.02.010. Epub 2011 Apr 8. Psychiatr Clin North Am. 2011. PMID: 21536165 Free PMC article. Review.
A review of SPECT studies in psychiatry in China.
Shi S, Shu L. Shi S, et al. Neuropsychiatr Dis Treat. 2006 Mar;2(1):43-51. Neuropsychiatr Dis Treat. 2006. PMID: 19412445 Free PMC article.

Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging - PubMed (original) (raw)